Latest News for: ai 10

Edit

Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint (Form 8-K) (Biofrontera Inc)

Public Technologies 09 Feb 2026
) ... vehicle gel (p<0.0003). ● Actinic keratosis (AK) is the most common skin condition diagnosed by US dermatologists1. ● If left untreated, AK may progress to squamous cell carcinoma2,3. WOBURN, Mass. (February 9, 2026) - Biofrontera Inc. (Nasdaq ... 2 ... 3.
Edit

Rancho Cordova’s Solidigm becomes part of its company’s AI $10 billion venture

Sacramento Bee 02 Feb 2026
Rancho Cordova-based Solidigm will become a subsidiary of the new AI solutions company, according to a news release ....
Edit

Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth (Form 8-K) (Biofrontera Inc)

Public Technologies 13 Jan 2026
). Biofrontera Inc ... ● Q4 year-over-year growth of 35% to 39% driven by sales execution of Ameluz®. ● Full year 2025 revenues also expected to show double-digit growth of 11% to 13%. WOBURN, Mass. (January 13, 2026) - Biofrontera Inc. (Nasdaq ... Ben Shamsian.
Edit

Failure to Satisfy Listing Rule (Form 8-K) (Biofrontera Inc)

Public Technologies 07 Jan 2026
To regain compliance, during this 180-day compliance period, the closing bid price of the Company's common stock must be at least $1.00 per share for a minimum of 10 consecutive business days ... Attachments Original document Permalink. Disclaimer ... (noodl.
Edit

Year Ender 2025: From DeepSeek to Agentic AI, 10 major developments that changed Artificial Intelligence i

The Times of India 27 Dec 2025
The year saw major shifts in global AI power with Chinas open-source DeepSeek R1 ...
Edit

Colfax boys basketball rallies to defeat 3A Central Valley

The Lewiston Tribune 07 Dec 2025
Canon Daines 0 0-0 0, Tysen Shelby 0 0-0 0, Cameron Walls 4 6-7 14, Jace Nordhagen 3 0-0 6, Orland Axton 3 2-2 10, Jacob Brus 1 0-0 3, Arjun Kandola 4 3-5 13, Isaac Plunkitt 2 0-0 4, Emerson Lippoldt 4 3-3 11 ... River View 14 10 8 15—48.
Edit

Initial Registration Statement (Form S-1) (Biofrontera Inc)

Public Technologies 05 Dec 2025
10.1111/j.1524-4725.2007.33224.x ... doi.10.1111/jdv.13180 ... DOI 10.1111/bjd ... The purchase price for the Acquired Assets (as defined in the APA) is a maximum of $10,000,000, payable as follows ... 10 ... 10.3# Amendment No ... 10.29 Amendment No.
Edit

Lord Rothermere’s Telegraph takeover strengthens UK media’s rightwing tilt

The Guardian 22 Nov 2025
Many fear competition and diversity will be diminished as Daily Mail owner wins race to buy newspaper.
Edit

Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update (Form 8-K) (Biofrontera Inc)

Public Technologies 13 Nov 2025
Conference call will be held today, Thursday, November 13 at 10.00 am ET ... Selling, general and administrative expenses were $10.4 million for the third quarter of 2025 compared with $8.4 million for the third quarter of 2024.
Edit

Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q) (Biofrontera Inc)

Public Technologies 12 Nov 2025
Certain statements in this Form 10-Q constitute "forward-looking statements" ... The purchase price for the acquired assets is a maximum of $10.0 million, payable as follows ... Selling, general and administrative 10,047 8,425 1,622 ... See Note 10.
Edit

Revolutionary Personal AI: Uare.ai’s $10.3M Bet on Digital Twin Technology That Captures Your Essence Forever

Bitcoin World 11 Nov 2025
This groundbreaking vision is now reality as immortality startup Eternos transforms into Uare.ai, securing $10.3 million in seed funding to revolutionize how we think about personal AI and digital preservation ... Feature Uare.ai Traditional AI Chatbots.
Edit

Material Event (Form 8-K) (Biofrontera Inc)

Public Technologies 10 Nov 2025
published this content on November 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 10, 2025 at 21.37 UTC.
Edit

Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M (Form 8-K) (Biofrontera Inc)

Public Technologies 07 Nov 2025
for up to $10M ● Proceeds of up to $10 million, consisting of $3 million at closing, $1 million upon availability of commercial product, and up to $6 million in sales-related milestone payments.
×